effects are similar to those of levodopa, but psychosis is more severe and may be more protracted despite withdrawal of the drug. When levodopa fails to control symptoms adding bromocriptine may allow a modest reduction of the dose of levodopa and produce an appreciable benefit in some patients. Intolerance, however, is not predictablenor is it necessarily related to dosage.
Pergolide is another potent, long acting postsynaptic dopamine agonist.'5 Like bromocriptine it is not effective in patients with primary levodopa failure, but about half the patients with on-off oscillations will derive benefit. Lisuride, a drug with similar potency to bromocriptine, reduces the off phase of on-off swings.'6 The toxicity of these three ergot derivatives is similar, and they remain valuable in extending the useful period of active treatment when the benefits of levodopa are waning or the patient's fluctuating performance is causing problems. The suggestion that low doses of bromocriptine should be given early in the disease in place of levodopa has not yet been substantiated and is not recommended. All of these ergot derivatives should be used with extreme caution in the elderly.
A recent, different approach has become possible with 1-deprenyl, a relatively specific inhibitor of monoamine oxidase-B which is claimed to have a selective stimulant action on the dopaminergic system.'7 A dose of 5-10 mg a day appears to have a weak potentiating action on levodopa. Used alone the antiparkinsonian action of 1-deprenyl is weak but it may be a mild stimulant of the amphetamine type. Its present place appears to be as an adjuvant in selective cases of advancing resistant disease.
At all stages we should aim to confine treatment to no more than two drugs at a time; these should be frequently reviewed with an eye to timing, duration of benefit, and side effects. Hourly charts of symptoms, activity, and side effects recorded by skilled observers throughout the day may allow fine adjustment and lead to new and useful strategies. Even at a late stage is is often surprising how much improvement results from a short period of hospital admission, simplification of treatment, and attention to detail in the domestic arrangements and mental attitudes to the patient's management. No ophthalmologist expresses an opinion on a fundus through an undilated pupil-a generalisation with few exceptions. The theoretical risk that mydriatic drugs may produce acute closed angle ("congestive") glaucoma has been overestimated.
Tropicamide 0-5% eye drops from sterile single dose capsules are almost ideal, because they produce a useful effect in about 20 minutes, which rises to a peak at 40-60 minutes; the effect passes off in six to eight hours.' Cyclopentolate 1% and homatropine 1% are less useful, because their action lasts about 24 hours. ' The effect of atropine lasts for a week or more so it is rarely used for viewing the fundus. 1 The individual response to all these drugs varies and is poorest in the dark brown iris. They act by weakening the sphincter muscle of the pupil: they are parasympatholytic. The tone of the dilator muscle, under sympathetic control, then enlarges the pupil; that action may be supplemented by the powerful adrenergic phenylephrine 10% to achieve wide mydriasis.2 Phenylephrine alone works moderately well with the same time relations as tropicamide. ' The mydriasis may be reversed within about an hour with pilocarpine 0 5% or 1%, which directly stimulates the muscle fibres ofthe pupillary sphincter. Many ophthalmologists omit that, however, because of the discomfort of strong miosis and spasm of the ciliary muscle (accommodation), preferring to allow the effect of mydriatics to decline with time. Thymoxamine 0 5% will selectively eliminate sympathetic stimulation only, and so is a precise way to reverse the effect of phenylephrine. 3 Without mydriasis the clinician will see only the optic disc reasonably well-at least in the elderly, because the older the patient the smaller the pupil. The very important macula and fovea are particularly difficult to see because stimulation of that area by the light of the ophthalmoscope will cause maximal constriction of the pupil through the pupillary light reflex arc. Evaluation of early cataract usually requires mydriasis. Some ofthe mysteries ofmedical retinopathies can be dispelled by the physician's seeing the fundus through a dilated pupil, especially if he has raised his probability of correct diagnosis by testing the patient's urine for sugar and recording the blood pressure beforehand.
The risk of producing acute closed angle (congestive) glaucoma is small. In a predisposed eye, dilatation of the pupil causes the peripheral iris to block the trabecular meshwork, the escape route for aqueous humour. This leads to a sudden rise in intraocular pressure and speedy loss of vision from corneal oedema ("steamy cornea"). The doctor should be wary of the patient with small eyeballs, corneas of small diameter, and shallow anterior chambers, especially if a parent or sibling is known to have glaucoma or has been admitted to an eye hospital for an emergency operation for glaucoma. A simple test may help to show that the pupil is on a more anterior plane than the periphery of the iris: shine a bright light with a concentrated beam from the temporal side along the plane of the iris. 4 If the nasal side of the iris is in shadow that suggests a shallow anterior chamber. Ifin doubt, dilate only one pupil with phenylephrine 10% and reverse its effect by thymoxamine 0-5%, leaving examination of the other eye for a subsequent visit.5 6
Other ocular side effects should be remembered. The patient will have some difficulty in reading with the treated eye(s) for the rest of the day unless his presbyopia is complete and he has full correction with spectacles. The explanation is that the ciliary muscle (for accommodation) is affected as well as the pupil. A chauffeur must be available to drive the patient home, since a car accident could be caused by glare when the sun is low in the sky.
Systemic toxic effects are possible from drugs in eye drops which sidestep initial detoxification by the liver,7 though these are rare when a small single dose is used.89 The patient may notice the taste of the drug as it drains into the nose and pharynx through the nasolacrimal duct, adding to the absorption by conjunctival blood vessels. Children and the elderly are most at risk. As might be expected, adrenergics may cause cardiac irregularities, with raised blood pressure, headache, trembling, and sweating; all these features may be worse in patients taking tricyclic antidepressants or monoamine oxidase inhibitors or being given halothane.'0
The parasympatholytics tend to produce effects on the central nervous system, from bad dreams to confusional psychosis.71'
